7600 — Japan Medical Dynamic Marketing Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSuper Stock

Annual income statement for Japan Medical Dynamic Marketing, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	18,083	16,738	19,193	21,308	23,178
Cost of Revenue
Gross Profit	12,804	11,418	12,989	13,993	14,762
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	15,405	14,660	16,373	19,557	21,637
Operating Profit	2,679	2,078	2,820	1,751	1,541
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,616	2,034	2,750	1,770	1,637
Provision for Income Taxes
Net Income After Taxes	2,187	1,681	2,142	1,436	1,305
Minority Interest
Net Income Before Extraordinary Items
Net Income	2,165	1,665	2,136	1,424	1,272
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2,165	1,665	2,136	1,424	1,272
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	80.9	65.9	76.3	62.5	54.6
Dividends per Share